Organ‐Specific Comorbidities Are Associated With Distinct Complications After Liver Transplantation for Biliary Atresia. Issue 5 (17th December 2021)

• Record Type: Journal Article
• Authors: Taylor, Sarah A.; Venkat, Veena; Arnon, Ronen; Gopalareddy, Vani V.; Rosenthal, Philip; Anderson, Sarah G.; Anand, Ravinder; Daniel, James F.
• Is Part Of: Liver transplantation. Volume 28:Issue 5(2022)
• Page Start: 855
• Page End: 866
• Publication Date: 2021-12-17
• Subjects: Liver -- Transplantation -- Periodicals; Liver -- Diseases -- Periodicals; Liver Transplantation -- Periodicals; Foie -- Greffe -- Périodiques; 617.5560592
• DOI: 10.1002/lt.26376
• Languages: English
• ISSNs: 1527-6465

Abstract

Abstract : Although transplant outcomes for biliary atresia (BA) have improved, there are few data to predict the risk of specific posttransplant complications. We therefore defined the impact of comorbidities in BA on posttransplant outcomes. Patients enrolled in the Society of Pediatric Liver Transplantation registry from 2011 to 2019 (n = 1034) were grouped by comorbidities of >1.0% incidence: any supplemental feeding, dialysis, other abdominal surgery (not Kasai portoenterostomy [KPE]), hepatopulmonary syndrome, and cardiac disease requiring intervention. Demographic and outcome data were compared using the Kruskal‐Wallis, chi‐square, and log‐rank tests. Cox proportional hazards models and binary logistic regression were performed for modeling. Patients with BA with comorbidities comprised 77% (n = 799) of our cohort and had evidence of greater medical acuity, including higher calculated Pediatric End‐Stage Liver Disease scores and hospitalizations in the intensive care unit before transplant ( P < 0.001 for both) versus those without comorbidities. After transplant, patients with BA with comorbidities had more graft loss ( P = 0.02), longer initial hospitalization and intubation ( P < 0.001 for both), and increased rates of reoperation ( P = 0.001) and culture‐proven infection ( P < 0.001) within 30 days after transplant. Only patients with BA with comorbidities on supplemental feed had increased rates of patient death ( P = 0.02). Multivariate analysis identified lower z weight and higher creatinine as risk factors for graft and patient loss in patients with BA with comorbidities. Prior KPE was protective against culture‐proven infection and vascular complications within 30 and 90 days, respectively. Patients with BA with comorbidities have evidence of higher medical acuity at transplant and reduced graft survival; however, they overall did not experience greater incidence of patient death. Our data provide organ‐system–specific data to risk‐stratify patients with BA and posttransplant outcomes.